Bitcore Capital Group Ltd (TLV:BITC)
Israel · Delayed Price · Currency is ILS · Price in ILA 38.60
+0.70 (1.85%)
At close: Aug 19, 2026
Bitcore Capital Group Revenue
In the year 2025, Bitcore Capital Group had annual revenue of 38.03M ILS, down -16.07%. Bitcore Capital Group had revenue of 18.63M in the half year ending December 31, 2025, with 44.17% growth.
Revenue
38.03M
Revenue Growth
-16.07%
P/S Ratio
0.40
Revenue / Employee
348.94K
Employees
109
Market Cap
15.20M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.03M | -7.28M | -16.07% |
| Dec 31, 2024 | 45.32M | 29.05M | 178.64% |
| Dec 31, 2023 | 16.26M | -190.00K | -1.15% |
| Dec 31, 2022 | 16.45M | 6.00M | 57.40% |
| Dec 31, 2021 | 10.45M | 8.52M | 440.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pomvom | 220.90M |
| Bio-View | 19.93M |
| Shamaym Improve | 3.26M |
| Axilion Smart Mobility | 1.80M |
| Foresight Autonomous Holdings | 1.33M |
| IBI Silver Castle | 1.05M |
| Nextage Therapeutics | 243.00K |
| Millennium Food Tech Limited Partnership | 29.00K |